Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study
Rheumatology 2020; doi:10.1093/rheumatology/keaa576
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatology 2020; doi:10.1093/rheumatology/keaa576
Ann Rheum Dis. 2019 Mar;78(3):320-327. DOI: 10.1136/annrheumdis-2018-214326
Arthritis Rheumatol. 2019 Jun;71(6):878-891
RMD Open. 2018 May 8;4(1):e000662. DOI: 10.1136/rmdopen-2018-000662
Rheumatology (Oxford) 2018; 57(2):309–17
Ann Rheum Dis 2017;76:1253-1262. DOI 10.1136/annrheumdis-2016-210457
Reumatol Clin. 2016; May 10 doi: 10.1016/j.reuma.2016.03.014 [Epub ahead of print]
Arthritis Rheumatol. 2015 May 4. doi: 10.1002/art.39183. [Epub ahead of print]
Arthritis Rheumatol. 2015;67(1):117–127
Arthritis Rheumatol. 2015;67(1):51–62